Procter & Gamble

Procter & Gamble has increased its dividend for 70 consecutive years and has paid uninterrupted dividends for 136 years. In the most recent quarter, revenue rose organically by 4 percent, and operating cash flow was $5.8 billion. In fiscal 2026, more than $10 billion was paid in dividends and around $5 billion went to share buybacks. The stock, with a forward P/E of about 24, is not cheap but—thanks to strong brands and stable cash flows—offers defensive stability compared with volatile tech names. » Więcej na deraktionaer.de

In the first fiscal quarter 2026/27, Procter & Gamble’s revenue rose 4.0% to USD 23.28 billion, with organic growth (adjusted) also at 4.0%; adjusted earnings per share climbed to USD 2.00 and beat expectations. The adjusted EBIT margin fell from 26.7% to 25.9% due to significantly higher raw material and transportation costs. Management slightly raised the sales outlook (2–4%), confirmed the adjusted EPS guidance of USD 6.89–7.11, and plans share buybacks and dividend payments of several billion dollars each; at the same time, higher raw material, interest and currency effects weighed on results. » Więcej na finanzen.net

The US consumer goods giant Procter & Gamble reported organic sales growth of 4% to $23.3 billion for the three months ended September, driven mainly by volumes with only modestly higher prices. Net income was about $4.7 billion, roughly flat year-on-year, and adjusted earnings per share rose 1% to $2.00. P&G confirmed its full-year targets: adjusted EPS to be flat to +3% ($6.89–$7.11) and organic sales growth of 1–3%; including the acquisition of Thorne, sales are expected to increase 2–4%. The stock rose just over 5% in early trading. » Więcej na finanzen.net

Procter & Gamble extended its dividend streak to 70 years and yields nearly 3%, supported by fiscal 2026 revenue of about $87 billion (up 3%) and EPS of $6.62 (up 2%). Moody's upgraded the company's credit outlook to positive, citing sustainable free cash flow and earnings growth. The stock is down roughly 8% year‑over‑year and trades at forward and trailing P/E ratios above 20, suggesting it is not inexpensive despite the reliable payout. » Więcej na finance.yahoo.com

Moody’s has confirmed the ratings for Procter & Gamble and Gillette (Aa3/Prime-1) and has raised the rating outlook from stable to positive. The change is justified by sustained free cash flow, strong earnings growth driven by price increases, innovation and cost reductions, and solid credit metrics (retained cash flow/net debt well above 25%, debt/EBITDA below 2). The acquisition of Thorne for USD 3.8 billion will pro forma temporarily increase the leverage ratio to just above 1.6x, but is expected to decline again through integration, scale effects and cost optimization. Moody’s cites potential upgrades or downgrades depending on market shares, profitability, free cash flow and the company’s financial policy. » Więcej na de.investing.com